Skip to main content
Equibles

FIRST TRUST ADVISORS LP

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1125816 Wheaton, IL
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$11,163,512
+$3,148,584 QoQ
Shares Held
3,041,829
+16.5% QoQ
Ownership
0.568%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#23
of 344 holders
Holding Since
Sep 2022
13 quarters on record
Voting authority Sole 58% Shared 0% None 42%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $2,844,450,753 across 98 Biotechnology names. RXRX ranks #38 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 547,132 $341,158,687
2 INCY
Incyte Corp
 1,587,996 $180,015,226
3 CORT
Corcept Therapeutics Inc
 1,829,545 $159,078,937
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 289,179 $143,643,884
5 EXEL
Exelixis, Inc.
 2,543,353 $138,383,836
6 ALNY
Alnylam Pharmaceuticals, Inc.
 421,534 $126,894,380
7 KRYS
Krystal Biotech, Inc.
 324,900 $120,755,583
8 AXSM
Axsome Therapeutics, Inc.
 482,061 $117,994,070

All Filings in RXRX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,163,512 3,041,829
2026-03-31 $8,014,928 2,610,726
2025-12-31 $9,270,766 2,266,691
2025-09-30 $8,770,360 1,797,205
2025-06-30 $9,514,267 1,880,290
2025-03-31 $5,456,629 1,031,499
2024-06-30 $711,405 94,854
2024-03-31 $3,765,918 377,725
2023-12-31 $2,491,552 252,693
2023-09-30 $1,793,328 234,422
2023-06-30 $341,655 45,737
2022-12-31 $1,859,243 241,147
2022-09-30 $1,377,220 129,438